{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:06:29Z","timestamp":1790154389247,"version":"4.0.1"},"reference-count":45,"publisher":"MDPI AG","issue":"18","license":[{"start":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T00:00:00Z","timestamp":1789776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Ministry of Science and Education of the Russian Federation","award":["075-15-2025-475"],"award-info":[{"award-number":["075-15-2025-475"]}]},{"award":["075-15-2025-475"],"award-info":[{"award-number":["075-15-2025-475"]}],"id":[{"id":"https:\/\/ror.org\/00ghqgy32","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Background: Previous studies have demonstrated the efficacy of membrane-anchored C-peptides against HIV and have shown that the surface expression level of these peptides is critical for effective protective activity. Methods: Bicistronic genetic constructs were designed for GPI-anchored expression of protective C-peptides on the cell membrane. The constructs were delivered using lentiviral vectors and tested in primary CD4+ lymphocytes and hematopoietic stem cells. Results: The bicistronic configuration significantly enhanced surface expression levels compared to monocistronic constructs and allowed simultaneous expression of two distinct protective peptides, thereby potentiating their activity. Lentiviral vectors harboring these constructs conferred robust protection to primary CD4+ lymphocytes against HIV infection irrespective of viral tropism and provided a selective advantage to transduced cells upon challenge with replication-competent HIV strains. The bicistronic construct was also suitable for lentiviral transduction of hematopoietic stem cells. Conclusions: These findings establish bicistronic GPI-anchored C-peptide expression as a promising platform for generating HIV-resistant immune cells and highlight its potential for ex vivo gene therapy.<\/jats:p>","DOI":"10.3390\/cells15181704","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T09:01:38Z","timestamp":1789981298000},"page":"1704","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bicistronic Lentiviral Architecture Increases Surface Density of Membrane-Associated HIV Entry Inhibitors and Confers Tropism-Independent Protection to Modified Cells"],"prefix":"10.3390","volume":"15","author":[{"given":"Yaroslava V.","family":"Chervyakova","sequence":"first","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, Ministry of Science and Higher Education of the Russian Federation, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Alena V.","family":"Smirnova","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, Ministry of Science and Higher Education of the Russian Federation, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7576-2059","authenticated-orcid":false,"given":"Andrei E.","family":"Siniavin","sequence":"additional","affiliation":[{"name":"Federal State Budget Institution \u201cNational Research Centre for Epidemiology and Microbiology Named After Honorary Academician N. F. Gamaleya\u201d, The Ministry of Health of the Russian Federation, Moscow 123089, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasilisa E.","family":"Soldatova","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, Ministry of Science and Higher Education of the Russian Federation, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Diana D.","family":"Gamzik","sequence":"additional","affiliation":[{"name":"Zoological Institute of the Russian Academy of Sciences, Saint Petersburg 199034, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-1914","authenticated-orcid":false,"given":"Anna V.","family":"Tvorogova","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, Ministry of Science and Higher Education of the Russian Federation, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"given":"Islam M.","family":"Nakastoev","sequence":"additional","affiliation":[{"name":"Federal State Budgetary Institution National Medical Research Centre for Hematology, The Ministry of Health of the Russian Federation, Moscow 125167, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"investigation","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6460-9427","authenticated-orcid":false,"given":"Alexander V.","family":"Filatov","sequence":"additional","affiliation":[{"name":"National Research Center Institute of Immunology, Federal Medical Biological Agency of Russia, Moscow 115522, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3984-4927","authenticated-orcid":false,"given":"Natalia A.","family":"Kruglova","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, Ministry of Science and Higher Education of the Russian Federation, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"writing-review-editing","vocabulary":"credit"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0784-3011","authenticated-orcid":false,"given":"Alexandra Konstantia Y.","family":"Maslennikova","sequence":"additional","affiliation":[{"name":"Institute of Gene Biology, Russian Academy of Sciences, Ministry of Science and Higher Education of the Russian Federation, Moscow 119334, Russia"}],"role":[{"vocabulary":"crossref","role":"author"},{"role":"conceptualization","vocabulary":"credit"},{"role":"writing-original-draft","vocabulary":"credit"},{"role":"project-administration","vocabulary":"credit"},{"role":"methodology","vocabulary":"credit"},{"role":"investigation","vocabulary":"credit"},{"role":"funding-acquisition","vocabulary":"credit"},{"role":"visualization","vocabulary":"credit"},{"role":"validation","vocabulary":"credit"},{"role":"supervision","vocabulary":"credit"},{"role":"formal-analysis","vocabulary":"credit"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Maslennikova, A., and Mazurov, D. (2022). Application of CRISPR\/Cas Genomic Editing Tools for HIV Therapy: Toward Precise Modifications and Multilevel Protection. Front. Cell. Infect. Microbiol., 12.","DOI":"10.3389\/fcimb.2022.880030"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-Term Control of HIV by CCR5 Delta32\/Delta32 Stem-Cell Transplantation","volume":"360","author":"Nowak","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2791","DOI":"10.1182\/blood-2010-09-309591","article-title":"Evidence for the Cure of HIV Infection by CCR5\u039432\/\u039432 Stem Cell Transplantation","volume":"117","author":"Allers","year":"2011","journal-title":"Blood"},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Yukl, S.A., Boritz, E., Busch, M., Bentsen, C., Chun, T.-W., Douek, D., Eisele, E., Haase, A., Ho, Y.-C., and H\u00fctter, G. (2013). Challenges in Detecting HIV Persistence during Potentially Curative Interventions: A Study of the Berlin Patient. PLoS Pathog., 9.","DOI":"10.1371\/journal.ppat.1003347"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1038\/s41586-019-1027-4","article-title":"HIV-1 Remission Following CCR5\u039432\/\u039432 Haematopoietic Stem-Cell Transplantation","volume":"568","author":"Gupta","year":"2019","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2352-3018(20)30069-2","article-title":"Evidence for HIV-1 Cure after CCR5\u039432\/\u039432 Allogeneic Haemopoietic Stem-Cell Transplantation 30 Months Post Analytical Treatment Interruption: A Case Report","volume":"7","author":"Gupta","year":"2020","journal-title":"Lancet HIV"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5560","DOI":"10.1093\/nar\/gkv469","article-title":"MRNA Transfection of a Novel TAL Effector Nuclease (TALEN) Facilitates Efficient Knockout of HIV Co-Receptor CCR5","volume":"43","author":"Mock","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1056\/NEJMc1405805","article-title":"Shift of HIV Tropism in Stem-Cell Transplantation with CCR5 Delta32 Mutation","volume":"371","author":"Kordelas","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1089\/hum.2017.032","article-title":"Simultaneous Knockout of CXCR4 and CCR5 Genes in CD4+ T Cells via CRISPR\/Cas9 Confers Resistance to Both X4- and R5-Tropic Human Immunodeficiency Virus Type 1 Infection","volume":"29","author":"Yu","year":"2017","journal-title":"Hum. Gene Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s13578-017-0174-2","article-title":"Genome Editing of the HIV Co-Receptors CCR5 and CXCR4 by CRISPR-Cas9 Protects CD4+ T Cells from HIV-1 Infection","volume":"7","author":"Liu","year":"2017","journal-title":"Cell Biosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.exphem.2006.04.002","article-title":"Mutual, Reciprocal SDF-1\/CXCR4 Interactions between Hematopoietic and Bone Marrow Stromal Cells Regulate Human Stem Cell Migration and Development in NOD\/SCID Chimeric Mice","volume":"34","author":"Dar","year":"2006","journal-title":"Exp. Hematol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1084\/jem.20072513","article-title":"CXCR4 Is Required for the Quiescence of Primitive Hematopoietic Cells","volume":"205","author":"Nie","year":"2008","journal-title":"J. Exp. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/gt.2010.40","article-title":"Generation of Human TRIM5\u03b1 Mutants with High HIV-1 Restriction Activity","volume":"17","author":"Pham","year":"2010","journal-title":"Gene Ther."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1089\/hum.2007.108","article-title":"Human Immunodeficiency Virus Type 1 Restriction by Human\u2013Rhesus Chimeric Tripartite Motif 5\u03b1 (TRIM 5\u03b1) in CD34+ Cell-Derived Macrophages In Vitro and in T Cells In Vivo in Severe Combined Immunodeficient (SCID-Hu) Mice Transplanted with Human Fetal Tissue","volume":"19","author":"Anderson","year":"2008","journal-title":"Hum. Gene Ther."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1089\/hum.2015.059","article-title":"Preclinical Assessment of Mutant Human TRIM5\u03b1 as an Anti-HIV-1 Transgene","volume":"26","author":"Jung","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.omtm.2019.02.006","article-title":"Safety of CD34+ Hematopoietic Stem Cells and CD4+ T Lymphocytes Transduced with LVsh5\/C46 in HIV-1 Infected Patients with High-Risk Lymphoma","volume":"13","author":"Delville","year":"2019","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1038\/mtna.2015.10","article-title":"Engineering Cellular Resistance to HIV-1 Infection In Vivo Using a Dual Therapeutic Lentiviral Vector","volume":"4","author":"Burke","year":"2015","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"16007","DOI":"10.1038\/mtm.2016.7","article-title":"Multilineage Polyclonal Engraftment of Cal-1 Gene-Modified Cells and in Vivo Selection after SHIV Infection in a Nonhuman Primate Model of AIDS","volume":"3","author":"Peterson","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e0358921","DOI":"10.1128\/mbio.03589-21","article-title":"Engineering T-Cell Resistance to HIV-1 Infection via Knock-In of Peptides from the Heptad Repeat 2 Domain of Gp41","volume":"13","author":"Maslennikova","year":"2022","journal-title":"mBio"},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Pu, J., Wang, Q., Xu, W., Lu, L., and Jiang, S. (2019). Development of Protein- and Peptide-Based HIV Entry Inhibitors Targeting Gp120 or Gp41. Viruses, 11.","DOI":"10.3390\/v11080705"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"e01839-16","DOI":"10.1128\/JVI.01839-16","article-title":"A Helical Short-Peptide Fusion Inhibitor with Highly Potent Activity against Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus","volume":"91","author":"Xiong","year":"2017","journal-title":"J. Virol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e01177-19","DOI":"10.1128\/JVI.01177-19","article-title":"A Membrane-Anchored Short-Peptide Fusion Inhibitor Fully Protects Target Cells from Infections of Human Immunodeficiency Virus Type 1 (HIV-1), HIV-2, and Simian Immunodeficiency Virus","volume":"93","author":"Tang","year":"2019","journal-title":"J. Virol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"bbad459","DOI":"10.1093\/bib\/bbad459","article-title":"Unraveling Viral Drug Targets: A Deep Learning-Based Approach for the Identification of Potential Binding Sites","volume":"25","author":"Popov","year":"2023","journal-title":"Brief. Bioinform."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4149\/av_2015_03_247","article-title":"Monoclonal Antibody Profiling of Cell Surface Proteins Associated with the Viral Biofilms on HTLV-1 Transformed Cells","volume":"59","author":"Tarasevich","year":"2015","journal-title":"Acta Virol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Mazurov, D., Ilinskaya, A., Heidecker, G., Lloyd, P., and Derse, D. (2010). Quantitative Comparison of HTLV-1 and HIV-1 Cell-to-Cell Infection with New Replication Dependent Vectors. PLoS Pathog., 6.","DOI":"10.1371\/journal.ppat.1000788"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Kalinichenko, S., Komkov, D., and Mazurov, D. (2022). HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread. Viruses, 14.","DOI":"10.3390\/v14010152"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10591","DOI":"10.1128\/JVI.01940-15","article-title":"Improvement of HIV-1 and Human T Cell Lymphotropic Virus Type 1 Replication-Dependent Vectors via Optimization of Reporter Gene Reconstitution and Modification with Intronic Short Hairpin RNA","volume":"89","author":"Shunaeva","year":"2015","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/JVI.01044-07","article-title":"Modulation of Human Immunodeficiency Virus Type 1 Infectivity through Incorporation of Tetraspanin Proteins","volume":"82","author":"Sato","year":"2008","journal-title":"J. Virol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1038\/s41375-018-0106-0","article-title":"Clinical Use of Lentiviral Vectors","volume":"32","author":"Milone","year":"2018","journal-title":"Leukemia"},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Qin, J.Y., Zhang, L., Clift, K.L., Hulur, I., Xiang, A.P., Ren, B.-Z., and Lahn, B.T. (2010). Systematic Comparison of Constitutive Promoters and the Doxycycline-Inducible Promoter. PLoS ONE, 5.","DOI":"10.1371\/journal.pone.0010611"},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Kim, J.H., Lee, S.-R., Li, L.-H., Park, H.-J., Park, J.-H., Lee, K.Y., Kim, M.-K., Shin, B.A., and Choi, S.-Y. (2011). High Cleavage Efficiency of a 2A Peptide Derived from Porcine Teschovirus-1 in Human Cell Lines, Zebrafish and Mice. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0018556"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2\u2212\u0394\u0394CT Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eaan1145","DOI":"10.1126\/scitranslmed.aan1145","article-title":"A Distinct Hematopoietic Stem Cell Population for Rapid Multilineage Engraftment in Nonhuman Primates","volume":"9","author":"Radtke","year":"2017","journal-title":"Sci. Transl. Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/j.omtm.2020.07.010","article-title":"Purification of Human CD34+CD90+ HSCs Reduces Target Cell Population and Improves Lentiviral Transduction for Gene Therapy","volume":"18","author":"Radtke","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1042\/BST20240288","article-title":"Molecular Regulators of Chemotaxis in Human Hematopoietic Stem Cells","volume":"52","author":"Liu","year":"2024","journal-title":"Biochem. Soc. Trans."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1016\/j.cell.2022.04.039","article-title":"Mobilization-Based Chemotherapy-Free Engraftment of Gene-Edited Human Hematopoietic Stem Cells","volume":"185","author":"Pedrazzani","year":"2022","journal-title":"Cell"},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Miyazawa, H., and Wada, T. (2021). Reversion Mosaicism in Primary Immunodeficiency Diseases. Front. Immunol., 12.","DOI":"10.3389\/fimmu.2021.783022"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Leslie, G.J., Wang, J., Richardson, M.W., Haggarty, B.S., Hua, K.L., Duong, J., Secreto, A.J., Jordon, A.P.O., Romano, J., and Kumar, K.E. (2016). Potent and Broad Inhibition of HIV-1 by a Peptide from the Gp41 Heptad Repeat-2 Domain Conjugated to the CXCR4 Amino Terminus. PLoS Pathog., 12.","DOI":"10.1371\/journal.ppat.1005983"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.1182\/blood.V84.10.3344.3344","article-title":"Expression of CD4 by Human Hematopoietic Progenitors [See Comments]","volume":"84","author":"Louache","year":"1994","journal-title":"Blood"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"e010702","DOI":"10.1136\/jitc-2024-010702","article-title":"Tailoring CAR Surface Density and Dynamics to Improve CAR-T Cell Therapy","volume":"13","author":"Hudecek","year":"2025","journal-title":"J. Immunother. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Majumdar, S., and Murphy, P.M. (2018). Adaptive Immunodeficiency in WHIM Syndrome. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20010003"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1016\/j.bpj.2024.02.001","article-title":"Chemokine Receptor Distribution on the Surface of Repolarizing T Cells","volume":"123","author":"Mazalo","year":"2024","journal-title":"Biophys. J."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.cell.2015.01.014","article-title":"Chromothriptic Cure of WHIM Syndrome","volume":"160","author":"McDermott","year":"2015","journal-title":"Cell"},{"key":"ref_44","first-page":"629","article-title":"Clinical GDNF Delivery Methods for Parkinson\u2019s Disease","volume":"16","author":"Luz","year":"2026","journal-title":"J. Park. Dis."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Palasz, E., Wysocka, A., Gasiorowska, A., Chalimoniuk, M., Niewiadomski, W., and Niewiadomska, G. (2020). BDNF as a Promising Therapeutic Agent in Parkinson\u2019s Disease. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21031170"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1704\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:31:55Z","timestamp":1790152315000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/15\/18\/1704"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,19]]},"references-count":45,"journal-issue":{"issue":"18","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["cells15181704"],"URL":"https:\/\/doi.org\/10.3390\/cells15181704","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,19]]}}}